Stugeron, Tabletten - 25 Tablette(n) Swissmedic Key 32053041 Registration Holder JNTL Consumer Health II (Switzerland) GmbH Name Stugeron, Tabletten Date of registration 05.06.1968 Introduction of Sequence 05.06.1968 ATC-Classification Cinnarizine (N07CA02) Revision date 12.11.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.06.20. Show package size 25 Tablette(n) Index Therapeuticus (Swissmedic) 02.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680320530413 Medication Code Synthetika Pharmacode Disponibility
Composition cinnarizinum 25 mg, lactosum monohydricum 158.8 mg, maydis amylum, saccharum 15 mg, talcum, gossypii oleum hydrogenatum, povidonum K 90, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Cinnarizine 25 mg
Inactive agents Dose Gossypii Oleum Hydrogenatum Lactose Monohydrate 158.8 mg Maydis Amylum Povidonum K 90 Pro Compresso Saccharum 15 mg Talcum
Source Data was imported : 04.05.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
